Kelyniam Global Inc. logo

Kelyniam Global Inc. (KLYG)

Market Open
11 Jun, 20:00
OTC PINK OTC PINK
$
0. 14
0
0%
$
1.76M Market Cap
- P/E Ratio
- Div Yield
5,000 Volume
0 Eps
$ 0.14
Previous Close
Investors:
Add Transaction
Day Range
0.14 0.14
Year Range
0.05 0.3
Want to track KLYG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

KLYG trading today higher at $0.14, an increase of 0% from yesterday's close, completing a monthly increase of 7.6923% or $0.01. Over the past 12 months, KLYG stock gained 16.6667%.
KLYG is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2014, missed the consensus estimates by -0.006%. On average, the company has surpassed earnings expectations by 0.0001%, based on the last three reports.
Kelyniam Global Inc. has completed 1 stock splits, with the recent split occurring on Mar 05, 2009.
The company's stock is traded on one exchange.

KLYG Chart

Kelyniam Global Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BM
Bert Miller Miller Wealth Advisors LLC
6,000 $720 $840 $120 16.67%

Kelyniam Global Inc. (KLYG) FAQ

What is the stock price today?

The current price is $0.14.

On which exchange is it traded?

Kelyniam Global Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is KLYG.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.76M.

Has Kelyniam Global Inc. ever had a stock split?

Kelyniam Global Inc. had 1 splits and the recent split was on Mar 05, 2009.

Kelyniam Global Inc. Profile

- Industry
- Sector
Ross Bjella CEO
OTC PINK Exchange
488359100 CUSIP
US Country
9 Employees
- Last Dividend
5 Mar 2009 Last Split
- IPO Date

Overview

Kelyniam Global, Inc. is a prominent medical device manufacturer that specializes in the production of custom prosthetic cranial implants. With a strong focus on utilizing advanced computer-aided design (CAD) and computer-aided manufacturing (CAM) techniques, the company processes medical-grade polymers to create precision solutions for patients within the United States. Initially named Ketner Global Investments, Inc., the entity underwent a rebranding to its current title in December 2007, signaling its dedicated pivot towards medical innovations. Founded in 2005 and headquartered in Collinsville, Connecticut, Kelyniam Global has established itself as a pivotal player in the medical sector, serving a diverse clientele that includes surgeons, health systems, and payers alike.

Products and Services

At the core of Kelyniam Global’s offerings are its bespoke medical devices, specifically tailored to each patient's unique anatomy and medical requirements.

  • Custom Cranial Implants:

    These implants are designed using cutting-edge technology that allows for precision custom-fit solutions catered to the individual needs of patients requiring cranial restructuring. They are crafted utilizing advanced medical-grade polymers, ensuring both durability and biocompatibility.

  • Custom Maxilla-facial Implants:

    Dedicated to the reconstruction of facial and cranial structures, these implants provide solutions for patients in need of facial structural repairs or enhancements. Like the cranial implants, these are also produced using high-quality polymers and state-of-the-art manufacturing processes for accurate fit and optimal performance.

Contact Information

Address: 97 River Road
Phone: 800 280 8192